Although many people across the globe use GLP-1 agonists for diabetes management since they mimic the naturally produced glucagon-like peptide-1, in recent years there has been increasing evidence suggesting they might have a beneficial role in heart failure too [22]. This evidence concerns the gene GCG and diabetes mellitus.